Audited Financial Result for the Financial Year ended 31.03.2026

Revenue DeclinePat Growth 25pctExceptional ItemNegative Operating CashflowResults View source PDF

BIOFILCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.2%1-day move

₹35.40

prior close

₹35.09

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.3-0.5-0.3+1.4-3.2-2.5-0.3-0.6+0.8+1.2+0.3-1.4——

Up moveDown movePending

AI summary

Biofil Chemicals reported FY26 revenue of Rs 28.39 crore, down 15% from Rs 33.40 crore in FY25, due to factory renovation and upgradation under revised Schedule M of Drug & Cosmetics Rules. However, profit after tax surged 400% to Rs 2.79 crore from Rs 55.78 lakh, boosted by a one-time gain from disposal of an undertaking. EPS improved to Rs 1.71 per share from Rs 0.34. Operating cash flow turned negative at Rs 60.49 lakh due to higher working capital needs, though the company generated Rs 3.07 crore net cash increase overall.

Likely market impact

Revenue decline reflects temporary operational disruption from factory upgrades, but the strong PAT growth and improved profitability margins signal recovery potential once operations normalize. The positive net cash position and asset sale proceeds provide near-term financial stability.